15.03.2023 SHOP APOTHEKE EUROPE N.V.  NL0012044747

EQS-News: SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.


 

EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

15.03.2023 / 18:33 CET/CEST
The issuer is solely responsible for the content of this announcement.


SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

Sevenum, the Netherlands, 15 March 2023. The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM. In this position, he will succeed Stefan Feltens, who will retire after the expiration of his current 4-year term on 26 April 2023.

Björn Söder, chairman of the SHOP APOTHEKE EUROPE’s Supervisory Board: "On behalf of the entire Supervisory Board, I am delighted to welcome Olaf Heinrich to SHOP APOTHEKE EUROPE. With his extensive experience in the European online pharmacy industry and his broad network nationally and internationally, we are convinced that he is the right person to lead SHOP APOTHEKE EUROPE into its next phase of growth and to further strengthen its position as the leading e-pharmacy in Europe."

Born in Hamburg, Olaf worked for the online pharmacy DocMorris from 2008 until 2020, initially as a member of the Management Board. Just under a year later, he became CEO. As a team player with years of experience working at board level in a listed company, he has a deep understanding of the digitalisation of the healthcare systems. As member of the European Association of E-Pharmacies (EAEP) he is known to SHOP APOTHEKE EUROPE’s management for the last 15 years.

"I am very excited to join SHOP APOTHEKE EUROPE, an industry leader in the online pharmacy market," says Olaf Heinrich. "I am impressed by the growth and value SHOP APOTHEKE EUROPE has created for its customers and its shareholders over the past years. It is a pleasure for me to lead such a strong company and, together with the team, to generate additional value and to further grow SHOP APOTHEKE EUROPE’S online business."

In accordance with Dutch law, Olaf Heinrich will be proposed to be appointed as a member of the managing board by the next general shareholders' meeting of SHOP APOTHEKE EUROPE N.V. which will be held on 26 April 2023.

Olaf Heinrich will support SHOP APOTHEKE EUROPE as an advisor even before his official start on 1 August 2023 to get familiarised with his future tasks.

 



15.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1583659

 
End of News EQS News Service

1583659  15.03.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1583659&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 283,99 539,71 701,01 968,06 1.060,32 1.204,35 1.798,76
EBITDA1,2 -12,14 -15,56 -18,58 15,20 -38,73 -29,66 39,99
EBITDA-Marge3 -4,27 -2,88 -2,65 1,57 -3,65 -2,46
EBIT1,4 -19,20 -28,73 -33,45 -0,87 -65,70 -69,17 -17,30
EBIT-Marge5 -6,76 -5,32 -4,77 -0,09 -6,20 -5,74 -0,96
Jahresüberschuss1 -21,36 -33,61 -36,27 -16,77 -74,19 -77,65 -11,61
Netto-Marge6 -7,52 -6,23 -5,17 -1,73 -7,00 -6,45 -0,65
Cashflow1,7 -23,24 -23,54 -30,37 17,80 11,64 -29,11 61,46
Ergebnis je Aktie8 -2,25 -2,79 -2,78 -1,17 -4,15 -4,32 -0,73
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Redcare Pharmacy
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2AR94 130,000 Halten 2.644,52
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
72,22 0,00 0,00 -62,26
KBV KCV KUV EV/EBITDA
5,06 43,03 1,47 70,23
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 17.04.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 30.07.2024 05.11.2024 05.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-6,61% 6,18% -0,76% 39,82%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SHOP APOTHEKE EUROPE N.V.  ISIN: NL0012044747 können Sie bei EQS abrufen


E-Commerce , A2AR94 , RDC , XETR:RDC